These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1672604)

  • 1. Pharmacology of celiprolol.
    Louis WJ; Drummer OH; Tung LH
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1281-5. PubMed ID: 1672604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial agonist activity of celiprolol, a cardioselective beta-antagonist.
    Ochi S; Nakazawa M; Kimura T; Nakagawa Y; Imai S
    Eur J Pharmacol; 1991 Feb; 194(1):1-5. PubMed ID: 1676370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial agonist activity of celiprolol.
    Tung LH; Jackman G; Campbell B; Louis S; Iakovidis D; Louis WJ
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):484-8. PubMed ID: 7681512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological studies of celiprolol: I. Beta-blocking effect, intrinsic sympathomimetic activity, vasodilating and hypotensive effects].
    Miura A; Kimura Y; Inoue K; Matsuzaki T; Ochi S; Hamada K; Hayashi S; Tamura M; Kano S; Kimura K
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):191-200. PubMed ID: 1973398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
    Pittner H
    Wien Klin Wochenschr Suppl; 1985; 162():1-21. PubMed ID: 2861698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antagonist and partial beta agonist properties of celiprolol in isolated rat cardiac tissue.
    Smith RD; Cobuzzi A; Wolf PS; Pruss TP
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):147-61. PubMed ID: 2870551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of pindolol and celiprolol in rats.
    Nanoff C; Ströher M; Haschkowitz H; Schütz W; Pittner H
    Basic Res Cardiol; 1990; 85(1):88-95. PubMed ID: 1970235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the beta 1-adrenoceptor blocking agent celiprolol have alpha 2-adrenoceptor blocking properties?
    Pittner H
    Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):199-210. PubMed ID: 2883946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
    Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celiprolol: agonist and antagonist effects at cardiac beta 1- and vascular beta 2-adrenoceptors determined under in vivo conditions in the rat.
    Alvarez-Guerra M; Alda O; Garay RP
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):689-98. PubMed ID: 9205952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of vasodilatory beta-blocking drugs.
    Shanks RG
    Am Heart J; 1991 Mar; 121(3 Pt 2):1006-11. PubMed ID: 1671724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.
    Pruss TP; Khandwala A; Wolf PS; Grebow P; Wong L
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S29-32. PubMed ID: 2427849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of (+/-)-, (+)- and (-)-celiprolol on the rat left atria and portal vein.
    Doggrell SA
    J Pharm Pharmacol; 1992 Mar; 44(3):239-43. PubMed ID: 1354732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors.
    Neve KA; Molinoff PB
    Am J Cardiol; 1986 Apr; 57(12):17F-22F. PubMed ID: 2871741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
    Norris RJ
    Am J Cardiol; 1988 Feb; 61(5):14C-22C. PubMed ID: 2893531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between beta adrenoceptor occupancy and receptor down-regulation induced by beta antagonists with intrinsic sympathomimetic activity.
    Lima JJ
    J Recept Signal Transduct Res; 1996; 16(5-6):357-72. PubMed ID: 8968966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A; Nakahara H; Hara Y
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.